Chemical Property of 5-Nitroindole
Chemical Property:
- Appearance/Colour:Yellow-green cyrstalline solid
- Vapor Pressure:3.98E-05mmHg at 25°C
- Melting Point:141-143 °C
- Refractive Index:1.723
- Boiling Point:362.6 °C at 760 mmHg
- PKA:15.25±0.30(Predicted)
- Flash Point:173.1 °C
- PSA:61.61000
- Density:1.425 g/cm3
- LogP:2.59930
- Storage Temp.:-20°C
- Solubility.:Dichloromethane, Ethyl Acetate, Methanol
- XLogP3:2.5
- Hydrogen Bond Donor Count:1
- Hydrogen Bond Acceptor Count:2
- Rotatable Bond Count:0
- Exact Mass:162.042927438
- Heavy Atom Count:12
- Complexity:190
- Purity/Quality:
-
98% *data from raw suppliers
5-Nitroindole *data from reagent suppliers
Safty Information:
- Pictogram(s):
Xn,
Xi
- Hazard Codes:Xn,Xi
- Statements:
22-41
- Safety Statements:
26-39-45-36/37
- MSDS Files:
-
SDS file from LookChem
Total 1 MSDS from other Authors
Useful:
- Chemical Classes:Nitrogen Compounds -> Indoles
- Canonical SMILES:C1=CC2=C(C=CN2)C=C1[N+](=O)[O-]
-
Uses
Reactant for preparation of:? ;Pharmaceutically active 2-oxo-1-pyrrolidine analogues1? ;Tryptophan dioxygenase inhibitors pyridyl-ethenyl-indoles as potential anticancer immunomodulators2? ;Protein Kinase Inhibitors and antiproliferative agents3? ;Positive Allosteric Modulators of Metabotropic Glutamate Receptor 4 (mGlu4)4? ;Antifungal agents5? ;Cannabinoid receptor type 1 (CB1) antagonists6? ;Potential anticancer agents7? ;Potential antivascular agents8? ;Selective Anti-leukemic agents9? ;Anti human immunodeficiency virus subtype 1 ( 5-Nitroindole (cas# 6146-52-7) is a compound useful in organic synthesis. Reactant for preparation of:Pharmaceutically active 2-oxo-1-pyrrolidine analoguesTryptophan dioxygenase inhibitors pyridyl-ethenyl-indoles as potential anticancer immunomodulatorsProtein Kinase Inhibitors and antiproliferative agentsPositive Allosteric Modulators of Metabotropic Glutamate Receptor 4 (mGlu4)Antifungal agentsCannabinoid receptor type 1 (CB1) antagonistsPotential anticancer agentsPotential antivascular agentsSelective Anti-leukemic agentsAnti human immunodeficiency virus subtype 1 (HIV-1) agents